Biguanides enhance antifungal activity against Candida glabrata

Candida spp. are the fourth leading cause of nosocomial blood stream infections in North America. Candida glabrata is the second most frequently isolated species, and rapid development of antifungal resistance has made treatment a challenge. In this study, we investigate the therapeutic potential of...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Shuying Xu, Marianela Feliu, Allison K. Lord, Daniel P. Lukason, Paige E. Negoro, Nida S. Khan, Zeina Dagher, Michael B. Feldman, Jennifer L. Reedy, Samantha N. Steiger, Jenny M. Tam, Alexander A. Soukas, David B. Sykes, Michael K. Mansour
Формат: Artigo
Язык:Inglês
Опубликовано: Taylor & Francis Group 2018-12-01
Серии:Virulence
Предметы:
Candida
Candida glabrata
biguanide
drug resistance
metformin
minimum inhibitory concentration (MIC)
Online-ссылка:http://dx.doi.org/10.1080/21505594.2018.1475798
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы